Recruiting Benign Prostatic Hyperplasia Studies in Omaha
About Benign Prostatic Hyperplasia Clinical Trials in Omaha
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that can cause urinary symptoms in men. It becomes increasingly common with age, affecting most men over 50. Treatment includes alpha-blockers, 5-alpha reductase inhibitors, and minimally invasive procedures.
There are currently 1 benign prostatic hyperplasia clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 206 participants. Research is being sponsored by Olympus Corporation of the Americas. Clinical trial participation is free and participants receive study-related medical care at no cost.
Benign Prostatic Hyperplasia Clinical Trials in Omaha — FAQ
Are there benign prostatic hyperplasia clinical trials in Omaha?
Yes, there are 1 benign prostatic hyperplasia clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Omaha?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.
Are clinical trials in Omaha free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.
What benign prostatic hyperplasia treatments are being tested?
The 1 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for benign prostatic hyperplasia.
Data updated July 19, 2026 from ClinicalTrials.gov